BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2166285)

  • 1. Unresponsiveness of insulinoma cells to secretin: significance of the secretin test in patients with insulinoma.
    Imamura M; Hattori Y; Nishida O; Honda T; Shimada Y; Miyahara T; Wagata T; Baba N; Tobe T
    Pancreas; 1990 Jul; 5(4):467-73. PubMed ID: 2166285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of suppression of insulin secretion by exercise in patients with insulinoma.
    Järhult J; Ericsson M; Holst J; Ingemansson S
    Clin Endocrinol (Oxf); 1981 Oct; 15(4):391-4. PubMed ID: 6274547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of secretin-responsive insulinoma with low serum C-peptide levels.
    Fujikura J; Hosoda K; Noguchi M; Ebihara K; Masuzaki H; Hirata M; Fujimoto K; Doi R; Iwanishi M; Nakao K
    Endocr J; 2007 Feb; 54(1):113-21. PubMed ID: 17146148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Portal, hepatic and peripheral insulin immunoreactive substances before and after removal of an insulinoma.
    Villaume C; Beck B; Pointel JP; Drouin P; Debry G
    J Endocrinol Invest; 1982; 5(5):315-21. PubMed ID: 6296220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of exogenous hyperinsulinemia on proinsulin secretion in normal man, obese subjects, and patients with insulinoma.
    Koivisto VA; Yki-Järvinen H; Hartling SG; Pelkonen R
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1117-20. PubMed ID: 3020076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An insulinoma for which secretin test and selective arterial calcium injection test were useful.
    Tanaka N; Hosoi M; Yamamoto T; Yoshioka K; Ishii T; Sato T; Tanaka S; Yamazaki O; Manabe T; Toyokawa A; Fujii S
    Intern Med; 2002 Oct; 41(10):839-41. PubMed ID: 12413006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid assay of insulin in portosplenic blood for insulinoma.
    Yao CZ; Zeng XJ; Niu ZP
    Chin Med J (Engl); 1984 Jan; 97(1):57-60. PubMed ID: 6329612
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma insulin response to various secretagogues in insulinoma.
    Ohneda A; Kobayashi T; Nihei J
    Tohoku J Exp Med; 1982 Apr; 136(4):447-57. PubMed ID: 6285549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of suppression of insulin secretion by hyperinsulinemia in a patient with an insulinoma.
    Cohen P; Barzilai N; Bar-Ilan R; Yassin K; Karnieli E
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1411-3. PubMed ID: 3023422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoreactive insulin assay in insulinoma.
    Zeng XJ; Yao CZ; Zhong SX; Zhang JX; Zhu Y; Wu CY
    Chin Med J (Engl); 1983 Aug; 96(8):575-82. PubMed ID: 6315315
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of intraoperative insulin monitoring in surgical management of insulinoma.
    Amikura K; Nakamura R; Arai K; Kobari M; Matsuno S
    J Laparoendosc Adv Surg Tech A; 2001 Aug; 11(4):193-9. PubMed ID: 11569507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 28-hour profiles of blood glucose (BG), plasma immunoreactive insulin (IRI) and IRI/BG ratio in four insulinomas.
    Villaume C; Beck B; Dollet JM; Pointel JP; Drouin P; Debry G
    Ann Endocrinol (Paris); 1984; 45(3):155-60. PubMed ID: 6098216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exaggerated insulin secretory response in patients with insulinomas to midaglizole, a drug with alpha 2-adrenergic blocking activity.
    Yamada Y; Kono N; Hanafusa T; Mineo I; Namba M; Itoh H; Kiyokawa H; Kawachi M; Yamasaki T; Tarui S
    Clin Endocrinol (Oxf); 1988 Jul; 29(1):29-34. PubMed ID: 2854759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on insulin secretion by monolayer cultures of normal and tumorous human pancreatic cells. Effects of glucose, somatostatin and SMS 201-995.
    Oosterom R; Verleun T; Uitterlinden P; Bruining HA; Bruining GJ; Verschoor L; Lamberts SW
    J Endocrinol Invest; 1987 Dec; 10(6):547-52. PubMed ID: 2894388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surgical treatment of insulinomas and the incretory function of the pancreas].
    Dubitskiĭ AE; Kozhara SP; Lifshits IuZ; Mel'nik LF
    Klin Khir (1962); 1987; (11):26-8. PubMed ID: 2832653
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dynamics of the blood serum protein fractions in patients with insulinoma].
    Dubitskiĭ AE; Deev VA; Gaevskaia VA; Polevik NF
    Vrach Delo; 1989 Dec; (12):71-4. PubMed ID: 2560876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Insulin assay in insulinoma].
    Zeng XJ
    Zhonghua Wai Ke Za Zhi; 1984 Jan; 22(1):13-8, 62. PubMed ID: 6097422
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of the artificial pancreas during surgery of insulinoma: experience with 3 cases].
    Goicolea Opacua I; Martínez Castillo A; Vázquez García JA
    Rev Clin Esp; 1988 Mar; 182(5):267-9. PubMed ID: 2840694
    [No Abstract]   [Full Text] [Related]  

  • 19. [Metabolism of insulin and immunoreactive insulin-like substances (proinsulin, HWIRI) in vivo in man].
    Villaume C; Beck B; Pointel JP; Drouin P; Debry G
    Ann Endocrinol (Paris); 1982; 43(1):15-21. PubMed ID: 6291446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-induced GIP levels in patients with insulinoma.
    Tamburrano G; Lala A; Mauceri M; Leonetti F; Andreani D
    Horm Metab Res; 1984 Dec; 16 Suppl 1():200-3. PubMed ID: 6099816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.